A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

NCT07227636 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

284

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Rectal Cancer

Interventions

DRUG: Botensilimab
DRUG: Balstilimab
OTHER: Placebo

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]